United States Liver Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Angiosarcoma, and Liver Metastasis), By Therapy (Targeted Therapy, Chemotherapy and Radiation Therapy, Immunotherapy, and Others), By Equipment (Computed Radiography, Sonography, MRI, and Others), By Factors (Cirrhosis, Nonalcoholic Fatty Liver Disease, Excessive Alcohol Consumption, and Others), By Route of Administration (Oral, Intravenous, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast and Opportunities, 2028

Published	Pages	Publisher	Report code
Oct 2023	88	TechSci Research	ASDR-638461

Published: Oct 2023 - Pages : 88 - Publisher : TechSci Research - Report code : ASDR-638461

1. Bristol-Myers Squibb
2. Merck & Co.
3. Bayer AG
4. Eli Lilly and Company
5. Novartis International AG
6. Ipsen Biopharmaceuticals Inc.